[1] Angeli P, Garcia-Tsao G, Nadim MK, et al. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the international club of ascites (ICA) consensus document. J Hepatol, 2019, 71(4):811-822. [2] Francoz C, Nadim MK, Durand FO. Kidney biomarkers in cirrhosis. J Hepatol, 2016, 65(4):809-824. [3] Jiang QQ, Han MF, Ma K, et al. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis. World J Gastroenterol, 2018, 24(21):2300-2310. [4] 中华医学会感染病学分会, 中华医学会肝病学分会, 北京大学第一医院感染疾病科肝病中心, 等. 慢性乙型肝炎防治指南(2019年版).实用肝脏病杂志, 2020, 23(1):9-32. [5] Fede G, D'Amico G, Arvaniti V, et al. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol, 2012, 56(4):810-818. [6] Theresa B, Elisabeth K. Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome. Gastroenterol Rep, 2017, 5(2):127-137. [7] Pose E, Cardenas A. Translating our current understanding of ascites management into new therapies for patients with cirrhosis and fluid retention. Dig Dis, 2017, 35(4):402-410. [8] Adebayo D, Neong SF, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol, 2019, 114(1):40-47. [9] Parr SK, Siew ED. Delayed consequences of acute kidney injury. Adv Chron Kid Dis, 2016, 23(3):186-194. [10] Umemura T, Joshita S, Shibata S, et al. Renal impairment is associated with increased risk of mortality in patients with cirrhosis: a retrospective cohort study. Medicine, 2019, 98(6):e14475. [11] 曾龙驿, 江玮. 重视糖尿病肾病发生机制的研究. 中华医学杂志, 2016, 96(17):1313-1314. [12] 王文娟, 宋琦, 丁惠国. 肝硬化患者急性肾损伤的临床特点及危险因素分析. 中华内科杂志, 2018, 57(12):912-916. [13] Wong F, Jepsen P, Watson H, et al. Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites. Liver Int, 2018, 38(10):1785-1792. [14] Wong F. The evolving concept of acute kidney injury in patients with cirrhosis. Nat Rev Gastroenterol Hepatol, 2015, 12(12):711-719. [15] Levy GD, Rashid N, Niu F, et al. Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia. J Rheumatol, 2014, 41(5): 955-962. [16] Barreto R, Fagundes C, Guevara M, et al. Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival. Hepatology, 2014, 59(4):1505-1513. [17] Devani K, Charilaou P, Jaiswal P, et al. Trends in hospitalization, acute kidney injury, and mortality in patients with spontaneous bacterial peritonitis. J Clin Gastroenterol, 2019, 53(2):e68-e74. [18] 崔瑞冰, 阎明. 肝肾综合征的病理生理学及诊疗进展. 中华肝脏病杂志, 2017, 25(4):246-248. [19] Møller S, Lee SS. Cirrhotic cardiomyopathy. J Hepatol, 2018, 69(4):958-960. [20] 刘艺琪, 王芳芳, 李萍. 乙型肝炎肝硬化并发急性肾损伤的影响因素. 中华传染病杂志, 2018, 36(12):752-754. |